PAA 0.00% 17.0¢ pharmaust limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-910

  1. 12,032 Posts.
    lightbulb Created with Sketch. 6152
    They do not have enough cash to reach October 2023 , so the Oppies will be impeded with a CR. Unless a commercial outcome is reached with a K9 Cancer Organisation or the Flux Capacitor lights up Shells BOD...

    The Company squandered Headlines and has ignored Covid, Yes Dragged the chain and avoided the Scientific Trialing Process,, otherwise we would have trialed MPL on a Mouse a week after WEHI 2 results came in..and then Humans 4 weeks after that, the FDA and Regulators lowered the regulatory bar to allow "Interim FDA Approval" to get Oral Treatments to Market...
    OHHHH plus Management ignored $65m AUD of Govt Grants to Trial Covid Treatments.....

    for reference regarding Pi55 Poor Reporting here are previous Announcements under the previous CEO.
    You can see Dogs being recruited and Dosed was News worthy? NOW no SH have any detail at all on K9 Trialing , recruitment and results?
    May 2015
    26thResults of Meeting
    26thEGM Shareholder Presentation
    19thSecond Dog Shows Suppression of Cancer Marker at Days 3 & 7
    11thReduction of further Cancer Marker confirmed in Human Trial
    1stFirst Dog Shows Suppression of Cancer Marker
    April 2015

    Then there was the Consolidation

    Number on issue before reorganisation 1,840,069,106 yes thats 1.8B shares
    Number on issue after reorganisation 92,003,455

    Since then the Share Register has Trippled with CR's to 320m with an additional 90m Oppies

    There used to be a level of excitement and progress was highlighted and published ,,, if you read the previous AGM 2016 2017 2018 2019 notes you will recognize the language. Same same same ..... AGM will be the day of reckoning this year SH will want comprehensive answers to questions ignored by the BOD and Management...

    Why no Mouse Trial?
    Why no movement on Human Cancer Phase II as that's what $6.4m was raised for from Bishops stand up in Perth @12c....
    No announcement for the Shell deal which is a Pilot Plant being built and cash content?
    What has Kim done? , 3 years since Elanco walked and bought Aratana for $245m USD and are selling Tanovea the oral treatment for Lymphoma like hot cakes.... Roger grinned and told us 4 days after Elanco walked , we have interested Parties , oh Big Pharma ,, 3 years ago?

    Cash Position will dictate the companies movements now , could have pushed Covid during the Biotech Boom , some companies doubled and trippled their SP and "yes " held a CR to gather up cash......... PAA "we are off to 6 clinics in 4 European Countries" Bullshit....

    Company has all the components to be hugely successful , MPL in my books is a winner..... Management have smothered this technology in wasted moments and just will not engage with Investors eg , NO presence on HC ,, who's at the top of our page today? who has the corporate sponsor video at the top of the page?? not PAA thats for sure...

    Company has been crippled financially by poor messaging ,, even positive announcements that should be heralded and sung from the roof tops always has a negative connotation..

    Regrettably Management just dont have the skill, will or ability to engage with the Market as a Business, Commercial Venture,, thats why PAA has been tagged for 3 years as a Research Institute.... and thats why investors shy away,, no commercial tale to be told here , no increase in Value with 8 years of positive Trial results ,, $56m in venture capital raised,, and todays value of the Company ,,less than half.....NZT
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.000(0.00%)
Mkt cap ! $82.65M
Open High Low Value Volume
17.0¢ 18.0¢ 17.0¢ $94.51K 540.3K

Buyers (Bids)

No. Vol. Price($)
9 262452 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 40400 3
View Market Depth
Last trade - 12.25pm 15/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.